Metaplanet
3350
Oriental Land
4661
Mitsui O.S.K. Lines
9104
4
Toyota Motor
7203
5
Nippon Telegraph & Telephone
9432
JP Stock MarketDetailed Quotes
4888 Stella Pharma
- 319
- -4-1.24%
20min DelayTrading Apr 30 14:42 JST
10.86BMarket Cap-12.94P/E (Static)
323High315Low60.40KVolume320Open323Pre Close19.25MTurnover60252wk High0.30%Turnover Ratio34.03MShares28152wk Low-22.92EPS TTM6.35BFloat Cap1070Historical HighLossP/E (Static)19.91MShs Float229Historical Low-24.66EPS LYR2.48%Amplitude--Dividend TTM3.53P/B100Lot Size--Div YieldTTM
About Stella Pharma Company
Stella Pharma Corp is a therapeutic drug research and development company. It is focused on the development of boron compounds, particularly used in boron neutron capture therapy (BNCT). The BNCT is a form of cancer radiation therapy for destroying cancer cells.
Company Profile
Symbol4888
Company NameStella Pharma
Founded2007-06-01
MarketTSE Growth
Fiscal Year Ends03-31
Address3-2-7 Korai-bashi Chuo-ku, Osaka Prefecture
Zip Code541-0043
Phone06-4707-1516
Websitewww.stella-pharma.co.jp
Company Executives
- Name
- Position
- Salary
- Koki Uehara
- Representative Director and President
- --
- Wako Yabu
- Director
- --
- Toshimitsu Hayashi
- Director
- --
- Takahiro Kido
- Director
- --
- Takashi Fukuchi
- Independent Director
- --
- Masaya Oonishi
- Independent Director
- --
- Kohei Tsujii
- Independent Director
- --